- Home
- INKT vs LVTX Comparison
INKT vs LVTX Comparison
Compare INKT & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- LVTX
- Stock Information
- Founded
- INKT 2017
- LVTX 2016
- Country
- INKT United States
- LVTX Netherlands
- Employees
- INKT N/A
- LVTX N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- LVTX Health Care
- Exchange
- INKT Nasdaq
- LVTX Nasdaq
- Market Cap
- INKT 33.6M
- LVTX 34.2M
- IPO Year
- INKT 2021
- LVTX 2021
- Fundamental
- Price
- INKT $7.25
- LVTX $1.31
- Analyst Decision
- INKT Strong Buy
- LVTX Hold
- Analyst Count
- INKT 2
- LVTX 3
- Target Price
- INKT $37.50
- LVTX $3.17
- AVG Volume (30 Days)
- INKT 5.5K
- LVTX 61.1K
- Earning Date
- INKT 05-13-2025
- LVTX 05-20-2025
- Dividend Yield
- INKT N/A
- LVTX N/A
- EPS Growth
- INKT N/A
- LVTX N/A
- EPS
- INKT N/A
- LVTX N/A
- Revenue
- INKT N/A
- LVTX $11,982,000.00
- Revenue This Year
- INKT N/A
- LVTX N/A
- Revenue Next Year
- INKT N/A
- LVTX N/A
- P/E Ratio
- INKT N/A
- LVTX N/A
- Revenue Growth
- INKT N/A
- LVTX 77.01
- 52 Week Low
- INKT $4.56
- LVTX $0.85
- 52 Week High
- INKT $13.79
- LVTX $3.20
- Technical
- Relative Strength Index (RSI)
- INKT 39.62
- LVTX 61.39
- Support Level
- INKT $7.23
- LVTX $1.03
- Resistance Level
- INKT $8.59
- LVTX $1.20
- Average True Range (ATR)
- INKT 0.72
- LVTX 0.08
- MACD
- INKT -0.10
- LVTX 0.00
- Stochastic Oscillator
- INKT 0.66
- LVTX 87.50
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.